AIM ImmunoTech Inc. (AIM) Shareholders’ equity 2016–2025
AIM ImmunoTech Inc. (AIM) shareholders’ equity at each fiscal year-end, per SEC filings.
-$9.8MFY2025 · since FY2016: $15.5M → -$9.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.8M | -640.0% |
| FY2024 | -$1.3M | -112.9% |
| FY2023 | $10.2M | -73.4% |
| FY2022 | $38.5M | -32.4% |
| FY2021 | $56.9M | -7.2% |
| FY2020 | $61.3M | +356.0% |
| FY2019 | $13.4M | +140.9% |
| FY2018 | $5.6M | -35.9% |
| FY2017 | $8.7M | -43.8% |
| FY2016 | $15.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice